{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:21Z","timestamp":1787026581248,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Aseptic meningitis represents a rare and underrecognized phenotype of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD). Despite sporadic case reports, comprehensive series studies remain scarce. This study aimed to describe the clinical characteristics of MOG antibody-associated aseptic meningitis (MOGAM) in pediatric patients without neuroparenchymal lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed the medical records of pediatric patients from January 2019 to July 2025, focusing on cases diagnosed with MOGAM in the absence of neuroparenchymal lesions. Clinical manifestations, brain magnetic resonance imaging (MRI) findings, laboratory results, treatment regimens, and clinical outcomes were retrospectively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 159 children with seropositive MOG antibodies, 11 (6.9%) met the inclusion criteria. The mean age at disease onset was 8.3 years (8.3 \u00b1 3.2 years), with a male-to-female ratio of 5:6. The most common symptoms were fever (10\/11), lasting from 3 to 50 days (median, 13 days; interquartile range [IQR], 8.0\u201322.7 days), and headache (10\/11). Meningeal irritation signs were positive in 4 patients (4\/11). Nine patients had peripheral blood leukocytosis (21.6 \u00b1 3.6\u00d710\n                      <jats:sup>9<\/jats:sup>\n                      \/L; range, 17.2\u201329.1\u00d710\n                      <jats:sup>9<\/jats:sup>\n                      \/L), and 10 had elevated neutrophil-to-lymphocyte ratio (NLR; median, 4.5; IQR, 4.0\u20137.9; range, 3.0\u201314.5) as well as erythrocyte sedimentation rate (ESR; 38.4 \u00b1 10.7 mm\/h; range, 25\u201362 mm\/h). All patients had cerebrospinal fluid (CSF) pleocytosis (117.4 \u00b1 62.0\/\u03bcL; range, 50\u2013201\/\u00b5L); 2 had elevated CSF pressure (range, 250\u2013350 mmH\n                      <jats:sub>2<\/jats:sub>\n                      O); 4 had slightly increased CSF protein levels (range, 0.48\u20130.96 g\/L); and none tested positive for infectious pathogens. Six patients showed abnormal electroencephalogram (EEG) results, including focal interictal epileptiform discharges or slow waves (3\/6) and slow background activities (5\/6). Brain MRI showed linear hyperintense signals along the bilateral cerebral sulci on fluid-attenuated inversion recovery (FLAIR) sequences in 4\u00a0patients (4\/11), while no abnormalities were observed in 7 patients (7\/11). Leptomeningeal enhancement (LME) was detected in 2 of 3 patients who underwent contrast-enhanced brain MRI. All patients received immunotherapy, with 2 administered immunosuppressive therapy after relapse. At the last follow-up, all patients achieved favorable clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Myelin oligodendrocyte glycoprotein antibody-associated isolated aseptic meningitis is a novel and underrecognized clinical phenotype. For pediatric patients presenting with prolonged or recurrent fever and headache, particularly those with CSF pleocytosis, leptomeningeal enhancement (LME), and poor response to anti-infective therapy, early testing for MOG-IgG is strongly recommended. Timely identification of this distinct phenotype may facilitate early diagnosis, initiation of effective immunotherapy, and better clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1699683","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:36:10Z","timestamp":1761197770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Myelin oligodendrocyte glycoprotein antibody-associated isolated aseptic meningitis: a single\u2212center pediatric case series"],"prefix":"10.3389","volume":"16","author":[{"given":"Kang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult Scler"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1212\/NXI.0000000000000503","article-title":"MOG antibodies in combined central and peripheral demyelination syndromes","volume":"5","author":"Vazquez Do Campo","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2021.03.006","article-title":"Prolonged fever: an atypical presentation in MOG antibody-associated disorders","volume":"122","author":"Udani","year":"2021","journal-title":"Pediatr Neurol"},{"key":"B5","article-title":"Six year old with chronic headache: an unexpected meningitis mimic","volume":"123","author":"Hadjiev","year":"2024","journal-title":"WMJ"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104126","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype","volume":"68","author":"Lin","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"476960","DOI":"10.1016\/j.jneuroim.2019.05.001","article-title":"MOG antibody seropositive aseptic meningitis: A new clinical phenotype","volume":"333","author":"Nagabushana","year":"2019","journal-title":"J Neuroimmunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1998.4684","article-title":"Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice","volume":"91","author":"Perrin","year":"1999","journal-title":"Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.10.003","article-title":"Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations","volume":"27","author":"Narayan","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102050","article-title":"MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boy","volume":"41","author":"Leinert","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1044642","article-title":"Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum","volume":"13","author":"Budhram","year":"2022","journal-title":"Front Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104939","article-title":"Characteristics of aseptic meningitis-like attack-an underestimated phenotype of myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"78","author":"Gu","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e200183","DOI":"10.1212\/NXI.0000000000200183","article-title":"Timing of MOG-igG testing is key to 2023 MOGAD diagnostic criteria","volume":"11","author":"Forcadela","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1055\/a-2579-6247","article-title":"MOG-encephalitis is the most prevalent autoimmune encephalitis in children: MERIN study data on encephalitis","volume":"56","author":"Fellmeth","year":"2025","journal-title":"Neuropediatrics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04558-4","article-title":"MOG antibody syndrome presenting as aseptic meningitis: an evolving spectrum","volume":"42","author":"Vibha","year":"2021","journal-title":"Neurol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2023.05.002","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease in a patient with symptoms of aseptic meningitis who achieved spontaneous remission: A case report and review of the literature","volume":"45","author":"Hino-Fukuyo","year":"2023","journal-title":"Brain Dev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.16189","article-title":"Steroid-responsive aseptic meningitis with raised intracranial pressure syndrome associated with myelin oligodendrocyte glycoprotein autoantibodies","volume":"58","author":"Wong","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/08830738211025867","article-title":"Rate of leptomeningeal enhancement in pediatric myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis","volume":"36","author":"Gadde","year":"2021","journal-title":"J Child Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331137","article-title":"Cerebral enhancement in MOG antibody-associated disease","volume":"95","author":"Elsbernd","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2024.01.026","article-title":"Leptomeningeal enhancement in pediatric anti-myelin oligodendrocyte glycoprotein antibody disease, multiple sclerosis, and neuromyelitis optica spectrum disorder","volume":"153","author":"Goldman-Yassen","year":"2024","journal-title":"Pediatr Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106446","article-title":"Clinical utility of complete blood count indices in pediatric MOG antibody-associated disease","volume":"98","author":"Kim","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"B23","doi-asserted-by":"publisher","first-page":"eabo7649","DOI":"10.1126\/science.abo7649","article-title":"Transforming the understanding of brain immunity","volume":"380","author":"Castellani","year":"2023","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2011.01011.x","article-title":"Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28\/\u200aB7 family","volume":"241","author":"Bour-Jordan","year":"2011","journal-title":"Immunol Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1699683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:36:10Z","timestamp":1761197770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1699683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2025.1699683"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1699683","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"article-number":"1699683"}}